Page 335 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 335
P1249 ALCOHOLIC LIVER DISEASE AND LIVER CANCER AS ePOSTERS
P1250 PUBLIC HEALTH ISSUES IN THE BURDEN OF LIVER-
P1251 RELATED MORTALITY IN THE LAST 15 YEARS IN BRAZIL
Hugo Perazzo*, Paula M. Luz, Raquel De Boni, Juliana Fittipaldi,
P1252 Sandra W. Cardoso, Beatriz Grinsztejn, Valdilea Veloso, Brazil
P1253
P1254 LOW INCIDENCE OF REINFECTION WITH HEPATITIS C
VIRUS AFTER SUCCESSFUL TREATMENT IN MONTREAL
Nima Machouf*, Benoit Trottier, Chrissi Galanakis, Emmanuelle Huchet,
Marc Poliquin, Sylvie Vézina, Stephane Lavoie, Danièle Longpré,
Danielle Legault, Réjean Thomas, Canada
HEPATITIS B AND C: KNOWLEDGE, ATTITUDES AND
PREVENTIVE PRACTICES OF THE GREEK GENERAL
ADULT POPULATION. PRELIMINARY RESULTS OF THE
GREEK NATIONAL HEALTH EXAMINATION SURVEY
“HPROLIPSIS”
Argiro Karakosta, Vana Sypsa, George Papatheodoridis,
Georgia Vourli, Olga Anagnostou*, Maria Kantzanou, Magda Gavana,
Apostolos Vantarakis, Gregory Chlouverakis, Paraskevi Voulgari,
Yannis Alamanos, George Rachiotis, Gregory Trypsianis, Giota Touloumi,
Greece
PREVALENCE OF HBV SEROLOGICAL MARKER IN
GENERAL HEALTHY POPULATION
Dongdong Li, Tingting Wang, Chuanmin Tao*, Qixia Chen,
Lanlan Wang, China
SIMULTANEOUS HIV-HBV-HCV POINT-OF-CARE TESTS
IMPROVE THE SCREENING OUTCOMES
Julie Bottero*, Anders Boyd, Joel Gozlan, Jean Nau, Marie-
Dominique Pauti, Pierre-Marie Girard, Karine Lacombe, France
HEPATITIS C SPONTANEOUS CLEARANCE MAY INDUCE
PARTIAL PROTECTION AGAINST REINFECTION AMONG
PERSONS WHO INJECT DRUGS: RESULTS FROM A COHORT
STUDY
Julie Bruneau*, Geng Zang, Didier Jutras-Aswad, Nathalie Bédard,
Marie-Eve Turcotte, Rachel Bouchard, Naglaa Shoukry, Elise Roy,
Canada
Vienna, Austria • April 22–26, 2015 335
P1250 PUBLIC HEALTH ISSUES IN THE BURDEN OF LIVER-
P1251 RELATED MORTALITY IN THE LAST 15 YEARS IN BRAZIL
Hugo Perazzo*, Paula M. Luz, Raquel De Boni, Juliana Fittipaldi,
P1252 Sandra W. Cardoso, Beatriz Grinsztejn, Valdilea Veloso, Brazil
P1253
P1254 LOW INCIDENCE OF REINFECTION WITH HEPATITIS C
VIRUS AFTER SUCCESSFUL TREATMENT IN MONTREAL
Nima Machouf*, Benoit Trottier, Chrissi Galanakis, Emmanuelle Huchet,
Marc Poliquin, Sylvie Vézina, Stephane Lavoie, Danièle Longpré,
Danielle Legault, Réjean Thomas, Canada
HEPATITIS B AND C: KNOWLEDGE, ATTITUDES AND
PREVENTIVE PRACTICES OF THE GREEK GENERAL
ADULT POPULATION. PRELIMINARY RESULTS OF THE
GREEK NATIONAL HEALTH EXAMINATION SURVEY
“HPROLIPSIS”
Argiro Karakosta, Vana Sypsa, George Papatheodoridis,
Georgia Vourli, Olga Anagnostou*, Maria Kantzanou, Magda Gavana,
Apostolos Vantarakis, Gregory Chlouverakis, Paraskevi Voulgari,
Yannis Alamanos, George Rachiotis, Gregory Trypsianis, Giota Touloumi,
Greece
PREVALENCE OF HBV SEROLOGICAL MARKER IN
GENERAL HEALTHY POPULATION
Dongdong Li, Tingting Wang, Chuanmin Tao*, Qixia Chen,
Lanlan Wang, China
SIMULTANEOUS HIV-HBV-HCV POINT-OF-CARE TESTS
IMPROVE THE SCREENING OUTCOMES
Julie Bottero*, Anders Boyd, Joel Gozlan, Jean Nau, Marie-
Dominique Pauti, Pierre-Marie Girard, Karine Lacombe, France
HEPATITIS C SPONTANEOUS CLEARANCE MAY INDUCE
PARTIAL PROTECTION AGAINST REINFECTION AMONG
PERSONS WHO INJECT DRUGS: RESULTS FROM A COHORT
STUDY
Julie Bruneau*, Geng Zang, Didier Jutras-Aswad, Nathalie Bédard,
Marie-Eve Turcotte, Rachel Bouchard, Naglaa Shoukry, Elise Roy,
Canada
Vienna, Austria • April 22–26, 2015 335
